Polycythaemia Vera

Feb 06, 2025

JAKAFI’s demand continues to grow in Polycythemia Vera The therapeutic paradigm for Polycythemia Vera patients has shifted significantly in the last few years. Previously, the Polycythemia Vera treatment landscape was dominated by generic medicines such as aspirin, hydroxyurea, interferons, and phlebotomy unti...

Jan 05, 2022

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did not cease developing new treatments this year. The US Food and Drug Administration maintained a rapid rate of new drug approvals this year, all while managing the urgent examination of COVID-19 tests, treatments, and vaccines un...

Oct 17, 2016

Janus Kinase (JAK) inhibitors are the ones that inhibit the functional activity of enzymes that belong to Janus Kinase family such as JAK1, JAK2, JAK3 and TYK2 by interfering in the JAK-STAT signaling pathway. JAK Inhibitors are used for the treatment purpose in cancer and inflammatory diseases like rheuma...